U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944704) titled 'Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice' on April 18.
Brief Summary: Investigating the efficacy, safety, and molecular mechanism of Pentoxifylline supplementation in improving elevated direct bilirubin level and liver function tests in patients with hepatic and post-hepatic jaundice
Study Start Date: April 03, 2024
Study Type: INTERVENTIONAL
Condition:
Hepatobiliary Disorders
Intervention:
DRUG: Pentoxifylline
Patients will receive oral Pentoxifylline 400 mg twice daily in addition to supportive treatment, for 3 months.
Recrui...